Entering the NASH Race: Tips for Early Clinical Development
Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that affects over 17 million American...
Blog
The Next Frontier of Pharmacology: Micro Drug Delivery
Injectable medication can be burdensome for the patient, causing pain and discomfort, and can contri...
Blog
Know Your Numbers Campaign
Know Your Numbers Campaign At Celerion, our community outreach does not only serve to inform the pub...
Blog
Prediabetes, the New Normal in Early Clinical Research
Prediabetes, the New Normal in Early Clinical Research There is a growing shift in inclusion criteri...
Blog
Supporting the Next Major Health Epidemic
Supporting the Next Major Health Epidemic Non-alcoholic fatty liver disease (NAFLD)/Non-alcoholic st...